Filtered By:
Source: Reviews in Cardiovascular Medicine

This page shows you your search results in order of relevance. This is page number 7.

Order by Relevance | Date

Total 13479 results found since Jan 2013.

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Rev Cardiovasc Med. 2021 Mar 30;22(1):97-104. doi: 10.31083/j.rcm.2021.01.277.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology. Coronary microvascular rarefaction in HFpEF was first hypothesized in an autopsy study that showed how HFpEF patients had lower microvascular density and more myocardial fibrosis than control subjects. This was later confirmed in vivo when it was noted that HFpEF is associated with reduced myocardial flow reserve (MFR) at s...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Francesco Tona Roberta Montisci Laura Iop Giovanni Civieri Source Type: research

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Rev Cardiovasc Med. 2021 Mar 30;22(1):97-104. doi: 10.31083/j.rcm.2021.01.277.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology. Coronary microvascular rarefaction in HFpEF was first hypothesized in an autopsy study that showed how HFpEF patients had lower microvascular density and more myocardial fibrosis than control subjects. This was later confirmed in vivo when it was noted that HFpEF is associated with reduced myocardial flow reserve (MFR) at s...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Francesco Tona Roberta Montisci Laura Iop Giovanni Civieri Source Type: research

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Rev Cardiovasc Med. 2021 Mar 30;22(1):97-104. doi: 10.31083/j.rcm.2021.01.277.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology. Coronary microvascular rarefaction in HFpEF was first hypothesized in an autopsy study that showed how HFpEF patients had lower microvascular density and more myocardial fibrosis than control subjects. This was later confirmed in vivo when it was noted that HFpEF is associated with reduced myocardial flow reserve (MFR) at s...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Francesco Tona Roberta Montisci Laura Iop Giovanni Civieri Source Type: research

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Rev Cardiovasc Med. 2021 Mar 30;22(1):97-104. doi: 10.31083/j.rcm.2021.01.277.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology. Coronary microvascular rarefaction in HFpEF was first hypothesized in an autopsy study that showed how HFpEF patients had lower microvascular density and more myocardial fibrosis than control subjects. This was later confirmed in vivo when it was noted that HFpEF is associated with reduced myocardial flow reserve (MFR) at s...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Francesco Tona Roberta Montisci Laura Iop Giovanni Civieri Source Type: research

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Rev Cardiovasc Med. 2021 Mar 30;22(1):97-104. doi: 10.31083/j.rcm.2021.01.277.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology. Coronary microvascular rarefaction in HFpEF was first hypothesized in an autopsy study that showed how HFpEF patients had lower microvascular density and more myocardial fibrosis than control subjects. This was later confirmed in vivo when it was noted that HFpEF is associated with reduced myocardial flow reserve (MFR) at s...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Francesco Tona Roberta Montisci Laura Iop Giovanni Civieri Source Type: research

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Rev Cardiovasc Med. 2021 Mar 30;22(1):97-104. doi: 10.31083/j.rcm.2021.01.277.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology. Coronary microvascular rarefaction in HFpEF was first hypothesized in an autopsy study that showed how HFpEF patients had lower microvascular density and more myocardial fibrosis than control subjects. This was later confirmed in vivo when it was noted that HFpEF is associated with reduced myocardial flow reserve (MFR) at s...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Francesco Tona Roberta Montisci Laura Iop Giovanni Civieri Source Type: research

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Rev Cardiovasc Med. 2021 Mar 30;22(1):97-104. doi: 10.31083/j.rcm.2021.01.277.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology. Coronary microvascular rarefaction in HFpEF was first hypothesized in an autopsy study that showed how HFpEF patients had lower microvascular density and more myocardial fibrosis than control subjects. This was later confirmed in vivo when it was noted that HFpEF is associated with reduced myocardial flow reserve (MFR) at s...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Francesco Tona Roberta Montisci Laura Iop Giovanni Civieri Source Type: research

Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations
Rev Cardiovasc Med. 2021 Mar 30;22(1):191-198. doi: 10.31083/j.rcm.2021.01.262.ABSTRACTWe explored the degree to which political bias in medicine and study authors could explain the stark variation in Hydroxychloroquine (HCQ)/Chloroquine (CQ) study favorability in the US compared to the rest of the world. COVID-19/SARS-CoV-2 preprint and published papers between January 1, 2020-July 26, 2020 with Hydroxychloroquine and/or Chloroquine; 267 met study criteria, 68 from the US. A control subset was selected. HCQ/CQ study result favorability (favorable, unfavorable, or neutral) was noted. First and last main authors of each US ...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Andrew C Berry Russell S Gonnering Ivan Rodriguez Qianying Zhang Bruce B Berry Source Type: research